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Implementation of a large-scale breast cancer early detection
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experiences from 2 large states in India
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BACKGROUND: The Breast Health Initiative (BHI) was launched to demonstrate a scalable model to improve access to early diagnosis
and treatment of breast cancer. METHODS: A package of evidence-based interventions was codesigned and implemented with the
stakeholders, as part of the national noncommunicable disease program, through the existing primary health care system. Data from the
first 18 months of the BHI are presented. RESULTS: A total of 108,112 women received breast health education; 48% visited the health
facilities for clinical breast examination (CBE), 3% had a positive CBE result, and 41% were referred to a diagnostic facility. The concordance of CBE findings between health care providers and adherence to follow-up care improved considerably, with more women visiting
the diagnostic facilities and completing diagnostic evaluation within 1 month from initial screening, and with only 9% lost to followup. The authors observed a clinically meaningful decrease in time to complete diagnostic evaluation with biopsy, from 37 to 9 days.
CONCLUSIONS: The results demonstrate the feasibility and effectiveness of implementing a large-scale, decentralized breast cancer
early detection program delivered through the existing primary health care system in India. Cancer 2022;0:1-10. © 2022 The Authors.
Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society This is an open access article under the terms of the
Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
KEYWORDS: breast cancer, diagnosis, early detection, implementation, India.

INTRODUCTION
Breast cancer is the most common cancer among women in India,1,2 with an estimated 178,361 new cases and 90,408
deaths in 2020.2 The 5-year survival rate is less than 60%3 and is likely due to a combination of factors: limited breast
cancer awareness in the community and among health care providers,4 suboptimal access to services for early detection of
breast cancer resulting in late-stage diagnosis,5 and inequitable access to quality treatment.6 Furthermore, the anticipated
increase in breast cancer incidence is expected to challenge India’s health care system with an increase of 52.3% by 2040.1
To address the growing burden of noncommunicable diseases, the Ministry of Health and Family Welfare of the
Government of India launched the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular
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Diseases, and Stroke (NPCDCS) in 2010.7 The NPCDCS
includes guidance for population-based screening of all
women aged 30 to 65 years for breast and cervical cancer.7
However, operationalization and implementation of the
program have been slow and inconsistent.
Since 2018, Jhpiego, an international nonprofit
health organization affiliated with John’s Hopkins
University, has supported the Departments of Health in
the states of Uttar Pradesh (UP) and Jharkhand in developing a resource-appropriate, phased implementation
strategy for decentralized breast cancer early detection
and care, called the Breast Health Initiative (BHI). This
strategy was codesigned with local experts and stakeholders within the context of the NPCDCS program and was
based on guidelines developed by the Breast Health Global
Initiative (BHGI). The BHGI is a resource-
stratified
guideline for early detection, diagnosis, and treatment of
breast cancer in low-to-middle-income countries.8,9

In this article, we present the key strategies, interventions, and results from the first 18 months of the BHI
program. To our knowledge, this is one of the largest
efforts to implement and evaluate a breast cancer early
detection program in a public health setting in low-to-
middle-income countries.
MATERIALS AND METHODS
We have conducted a situational assessment5 of breast health
services in both states using the BHGI “BCI2.5 toolkit.”10
Based on the needs identified in the situational assessment5
and relevant stakeholder inputs, combined with the guidance included in NPCDCS,7 a context-appropriate implementation plan for breast cancer care delivery was created.
The BHI implementation plan included training
for and deployment of female community health workers
(who are called accredited social health activists [ASHAs])
to conduct tailored breast cancer awareness programs

Figure 1. Operational framework and resource-stratified care pathways for breast health services. ANM indicates auxiliary nurse
midwife; ASHA, accredited social health activist; FNAB, fine-needle aspiration biopsy; USG, ultrasonography.
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aimed at women aged 30 to 65 years and quality clinical breast examination (CBE) training for auxiliary nurse
midwives (ANMs), staff nurses, and medical officers at
the primary care clinics.
According to the framework (Fig. 1), frontline health
workers increase breast health awareness and encourage and
facilitate women who have breast symptoms to present to
the nearest primary-level health facility for CBE by trained
health care staff (auxiliary nurse midwives, facility-based
staff nurses, and/or physicians). Women with an abnormal
CBE are referred to district hospitals for confirmatory CBE,
imaging (breast ultrasound and/or mammography), fine-
needle aspiration biopsy (FNAB), and/or biopsy followed
by pathologic confirmation. Women with a confirmed case
of breast cancer are referred to the nearest medical college
or tertiary care center for further evaluation and treatment.
We established a robust monitoring and evaluation system at the onset of the program, so that all key data needed
for decision-making could be captured in a timely and reliable manner. A centralized digital dashboard (Supporting
Fig. 1) allowed for real-time monitoring of key indicators.
In this article, we analyzed data collected from
October 2018 to March 2020, including program

outreach, quality of CBE defined as concordance of CBE
findings between health care providers at the primary versus secondary levels of the health care system, adherence
to follow-up care for women with an abnormal CBE,
time to complete diagnostic evaluation, and confirmed
breast cancer diagnoses.
Program Sites

The BHI was implemented in UP and Jharkhand (Fig. 2).
The program sites were purposefully selected to represent
urban and rural settings, which can help future scale-up
efforts and sustainability in various settings. Both UP and
Jharkhand are high-focus states because of persistently
low health outcomes.11,12 The estimated age-standardized
incidence rate of breast cancer in UP and Jharkhand is
21.1 and 17.4 per 100,000 women, respectively.13
Ethical Considerations

The data analysis was performed with the approval of the
institutional review board of the Johns Hopkins School
of Public Health in accordance with an assurance filed
with and approved by the US Department of Health and
Human Services.

hƩĂƌWƌĂĚĞƐŚ

:ŚĂƌŬŚĂŶĚ

Figure 2. The intervention states.
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TABLE 1. Breast Health Implementation Strategies and Key Interventions
Breast Cancer Care Continuum
(Health-System Level)
Awareness/education (community
level)

Early detection/screening level
(primary care)

Diagnostic level (secondary or
tertiary care)

Cross-cutting

Strategies

Interventions

• Development of behavior-change communication materials in
the local language
• Orientation of frontline health workers on breast health and
importance of the community awareness program
• Awareness creation on importance of breast health, warning
signs, risk factors, breast self-examination, myths, misconceptions, and local cultural beliefs
• Integration of activities for breast health awareness into
existing community and primary health care programs and
platforms
• Orientation of frontline health care workers (staff nurses and
ANMs) about importance of history taking and CBEs for
women aged >30 y and high-risk women
• Competency-based training for health workers on proper CBE
techniques using anatomic models, job aids, and audiovisual
aids
• Development of protocols for CBE and management of benign
breast conditions
• Systematic integration of breast health care services at all
levels of the public health system and saturating the primary
health care level with capacity for CBE, toward increasing access to CBE for women
• Involvement of professional associations of gynecologists and
surgeons to undertake special orientation programs on CBE
and breast health care
• Orientation of all health care providers on importance of
history taking and CBE of women aged >30 y and high-risk
women
• Setting up “single-window breast health care clinics” with
presence of surgeons, radiologists, and pathologists, at the
diagnostic centers to reduce the number of visits undertaken
by women with suspicious lesions for diagnostic evaluation
• Task sharing: 1) competency-based training for general
physicians or surgical staff to undertake fine-needle aspiration
cytology or if feasible, core biopsy for further diagnosis; 2)
training for pathologist and laboratory technicians on specimen processing, slide preparation, fixation, and reporting
• Free diagnostic services for suspected cases and referral
tracking, including phone reminders
• Streamlining the diagnostic and treatment pathways to improve efficiency and access for patients
• Posting trained program staff at the health facility whose
primary responsibility was to support women to finalize diagnostic evaluation.
• Diagnostic breast ultrasound, when available and
mammography
• Availability of preliminary blood tests and staging investigations including chest x-ray and liver ultrasound
• Systems created for tracking and follow-up of patients across
the care pathway.
• Facility-level data compiled monthly for review by district/
state health authorities

• Job aids created: pictorial key chain for breast
health teaching with structured messaging on
CBE and signs and symptoms of breast cancer
• 1,159 ASHAs (74% of all ASHAs serving the
targeted catchment area) trained on community
awareness and education
• 498 staff nurses and ANMs (74% of targeted
staff nurses and ANM) from intervention facilities trained in CBE, documentation and referral,
and detection of benign breast conditions
• 140 medical officers (82% of targeted medical
officers) from intervention facilities trained in
CBE, documentation and referral, and management of benign breast conditions
• Screening offered at 225 facilities on designated
days
• Standardized measurement of breast lump with
vernier caliper

• Individual patient card completed with CBE
result and plan
• Individual patient referral slip (with unique identification) created for women with a CBE+ result
• ASHAs conducted follow-up reminders to
ensure women with a CBE+ result visited diagnostic centers for confirmatory CBE

Abbreviations: ANM, auxiliary nurse midwife; ASHA, accredited social health activist; CBE, clinical breast examination.

RESULTS
Table 1 summarizes the key implementation strategies
and corresponding results of the BHI, and Table 2 depicts
the timeline for key implementation activities

4

Program Outreach

Overall, 108,112 women were contacted by ASHAs in the
community for the breast health education, representing
approximately 16% of target-age women in program sites
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(Table 3). Forty-eight percent (52,248 women) visited the
health facilities for CBE, of which 1736 women (3%) had
a positive CBE result, out of which 708 women (41%)
visited a diagnostic facility. Of the latter, 423 women
(60%) were confirmed to have a positive CBE result on
repeat CBE by a medical officer or staff nurse, and 386
women (91%) underwent diagnostic evaluation. Twenty-
four women (8%) were ultimately confirmed to have
breast cancer, and 19 women (79%) began treatment.

April May June July August September October November December January February March April May June July August September October November December January February March

Training for Health Care Providers

Training effectiveness was assessed by pre-and post-tests
for knowledge of ASHAs, ANMs, staff nurses, and medical officers (multiple choice knowledge assessment tool)
and the CBE skills of ANMs, staff nurses and medical
officers (Objective Structured Clinical Examination
[OSCE]). The mean knowledge scores improved from
69% to 93%, whereas mean CBE skills improved from
21% to 95%.
Quality of CBE

The concordance level of CBE findings between health
care providers at the primary versus secondary levels of the
health care system was high (94%) after initial training,
and then it decreased in subsequent quarters to 45% to
50%. Based on facility-level data for volume and quality
of CBE performed, facilities were prioritized for supportive supervision visits to reinforce CBE skills in primary
care. As such, the CBE concordance level increased to
78% in the final quarter of program implementation.

Month 0, 2022

Abbreviations: ASHA, accredited social health activist.

Adherence to Follow-Up Care

Situational assessment
Breast Health Technical
Advisory Committee
Designing implementation
strategy
Facility assessment
Training for health care
providers
Enumeration by ASHAs
Supportive supervision
Monthly feedback sharing
with the facility
Monthly progress reports

Activities

2018

TABLE 2. Timeline of Key Implementation Activities

Year

2019

2020

Breast Cancer Program in India/Kumar et al

Over the project implementation period from October
2018 to March 2020, a total of 708 women (41%) with
a positive CBE result visited a diagnostic facility. During
the first 3 months, adherence was only 14%; however, adherence quickly doubled (37%) and was maintained by the
end of the reporting period (41%). Of the 423 women who
visited a diagnostic facility and were confirmed to have a
positive CBE result by the specialist, 386 (91%) completed
diagnostic evaluation. Of those who completed diagnostic
evaluation, 367 women underwent investigations without
biopsy, whereas 19 women underwent a biopsy (Table 4).
Of those who visited a diagnostic facility and were confirmed to have positive a CBE by the specialist, only 9%
were not able to complete diagnostic evaluation.
Average Time to Complete Diagnostic Evaluation

The average time to visit a diagnostic facility decreased
from 12 to 5 days by the last quarter of the project. Of
5
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TABLE 3. Summary of Results
Women, No.
Contact in the community
Visited health facility for CBE
Suspicious finding on CBE referred to
diagnostic facility
Visited diagnostic facility
Suspicious finding on repeat CBE
Completed diagnostic evaluation
Confirmed diagnosis of cancer to date
Initiated treatment
Women with staging information
available
Stage I and II
Stage III
Stage IV

Women, %

Patients With a Suspicious Finding on CBE, %

100
48
3.3

Not applicable
Not applicable
100

708
423
386
24
19
18

41
60
91
8
79
75

40.8
24.4
22.2
1.4
1.1
1.0

13
4
1

72
22
6

0.7
0.2
0.06

108,112
52,248
1736

Abbreviations: CBE, clinical breast examination.

those women with a positive CBE result at a diagnostic
facility, 80% completed a diagnostic evaluation within 1
month. The average time to complete a diagnostic evaluation without a biopsy remained unchanged, whereas the
average time to a complete diagnostic evaluation with biopsy was reduced from 37 to 9 days.
Among women with a positive CBE result who
underwent diagnostic evaluation, 91.2% underwent an
ultrasound, 7.7% underwent an FNAB, and 1.1% underwent a mammogram. Among women who received
an ultrasound, 68% underwent an ultrasound only,
20% underwent an ultrasound and an FNAB, 1.7% underwent an ultrasound, mammography, and an FNAB,
and 1.3% underwent an ultrasound and mammography
investigations. During the program implementation period, 75% of women with a positive CBE result underwent only 1 test, whereas 25% required more than 1
diagnostic test.
Breast Cancer Staging

We were able to collect staging details for 18 of the 24
women who were confirmed to have breast cancer. Of
the 18 cases for which complete staging information was
available, 13 (72%) were early stage (stage 1 and 2), 4
were locally advanced, and only 1 had metastatic disease
(Table 3).
DISCUSSION
During the first 18 months of implementation, we were
able to reach 16% of the eligible population, 48% of
which visited their nearby primary health care facility
for CBE screening. We have observed that the quality
of CBE and adherence to follow-up care among women
with abnormal CBE results improved considerably
6

through the course of the program, with more women
visiting the diagnostic facilities and completing diagnostic evaluation. We observed a significant decrease
in the proportion of women lost to follow-up; however, adherence remained low overall, with only 41%
of women with a positive CBE result at primary care
and reaching the next level of care for diagnostic evaluation. We also report a clinically meaningful decrease
in time to complete diagnostic evaluation with biopsy
from 37 to 9 days. Of the women in the program who
were diagnosed with breast cancer, 72% had early-stage
disease, which compares favorably with the previously
reported results.5
Low screening uptake and adherence to the care
pathway might have been affected by various factors
including low awareness in the community regarding breast cancer screening, lack of trained providers,
a fragmented health system, and poor coordination
across levels of the health system.14-16 The situational
assessment5 revealed low awareness about breast health
among health care providers and women in the community, with more than 75% of patients with breast cancer
reporting they had never undergone a CBE before their
cancer diagnosis.5 Furthermore, a pretest of knowledge
and skills conducted before training initiation showed
low knowledge (69%) and low CBE skills (21%) among
health care providers. We attempted to address these
issues with training for health care providers and implementing breast health awareness programming, including pragmatic information about breast screening
in the BHI and for those with symptoms to seek timely
diagnostics and treatment. Although we were not able
to formally interview patients who did not receive diagnostic and tertiary care in our program, existing
Cancer  
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9% (3)
13% (16)
6% (8)
13% (8)
3% (1)
2% (1)
9% (37)
6% (2)
20% (25)
10% (13)
5% (3)
3% (1)
7% (3)
11% (47)
84% (27)
66% (81)
83% (106)
82% (51)
94% (32)
91% (42)
80% (339)
32
122
127
62
34
46
423
59% (119)
60% (275)
58% (282)
60% (167)
62% (111)
57% (74)
59% (1028)
26% (53)
10% (44)
5% (25)
6% (16)
3% (5)
2% (2)
8% (145)
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14% (29)
31% (142)
37% (181)
34% (96)
35% (62)
41% (53)
32% (563)
201
461
488
279
178
129
1736
Oct-Dec 2018
Jan-Mar 2019
Apr-Jun 2019
Jul-Sep 2019
Oct-Dec 2019
Jan-Mar 2020
Overall

Lost to Follow-Up
>1 mo
Within 1 mo
Within 1 mo

>1 mo

Lost to Follow-Up

CBE Positive Cases at a
Diagnostic Facility, No.

Cancer  

Overall

Suspicious CBE Cases at
Screening Facilities

Women With Suspicious CBE Result at a Screening
Facility Who Visited a Diagnostic Facility, % (No.)

TABLE 4. Trend in Adherence of Patients with a CBE-Positive Result to the Care Pathway

Women With a Confirmed CBE Positive Result
at a Diagnostic Facility Who Completed a
Diagnostic Evaluation, % (No.)

Breast Cancer Program in India/Kumar et al

evidence suggests that adherence to care is influenced
by geographic and health system barriers, cultural beliefs and misconceptions regarding breast cancer, competing priorities, and financial barriers.5,17,18 Although
it is beyond the scope of the current study, we estimated
that approximately 40 patients with breast cancer could
have been missed because of nonadherence to follow-up
care. It is also possible that some women sought follow-up in the private sector for diagnostic evaluation
and subsequent treatment. According to Rajpal and colleagues,19 in 2014, 61% of patients with cancer in India
used private facilities; this figure was higher for female
patients. Moreover, visits to homeopathic practitioners
and home remedies for treatment of a breast lump are
common practice in both states.5 Adherence to diagnostics did improve over the project implementation
period, likely because of increased breast health awareness in the community and efforts to track patients in
need of follow-up. This implies the program was successful in ensuring timely completion of diagnosis.
Before the project implementation, more than 50%
of patients delayed seeking care with a health care provider on average 4 to 5 months.5 During the project implementation period, we observed a substantial decrease
in the average time to visit a diagnostic facility and to
complete diagnostic evaluation. This is an important
metric because delays between the discovery of a clinically
palpable breast finding and diagnosis of breast cancer
are associated with significantly lower survival,20 and the
BHGI framework suggests a target of no more than 60
days from the detection of an abnormal breast finding.21
Patient navigation has been shown to increase utilization and adherence to cancer screening services.22-26
Although we attempted to implement frugal mechanisms
for patient navigation that included reminder phone calls
to patients in need of follow-up, there is a need for further
strengthening of these patient-navigation systems.
Although the only modality currently recommended
by the World Health Organization for population-based
breast cancer screening is mammography,27 this comes
with essential caveats, along with critical programmatic
and technical requirements, all of which must be supported through sustainable financing.27,28 As such,
mammographic screening is recommended only in
high-
resource settings with robust, well-
financed, and
well-
coordinated health systems.27,28 In lower-
resource
settings, the WHO and the BHGI,9 recently having
joined forces in the Global Breast Cancer Initiative,29 recommend that the first critical step in a phased approach
to implementing breast health care is to ensure that all
7
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women with symptoms suggestive of breast cancer have
equitable access to timely diagnosis and care, also called
“early diagnosis.” Although early-
diagnosis strategies,
including capacity building, are being implemented in
India to ensure timely access to affordable diagnostic evaluation, the WHO advises consideration of using CBE as
a screening modality for asymptomatic women at an appropriate target-age range, in a more controlled setting,
ideally with implementation research methods to evaluate
processes and outcomes.27
During the 18 months implementation process that
we describe here, long-term data were published from
India by Mittra and colleagues30 showed, for the first time
in a high-quality randomized control trial, a clinically
meaningful (15%) reduction in breast cancer–
specific
mortality after screening by CBE. Although mortality
was statistically significant only for women older than 50
years, there was a trend toward mortality reduction overall. According to the literature,5,14 more than 50% of the
patients presenting to a cancer specialist were in stages
III and IV, whereas, after implementation of this breast
cancer program, 72% of patients with breast cancer were
diagnosed with early-stage breast cancer. According to the
Global Breast Cancer Initiative’s recent estimates, countries with reduction in age-
standardized breast cancer
mortality had at least 60% of patients with invasive breast
cancer presenting as stage I or II disease at the population
level.31 Our program might be considered a related effort
to demonstrate that a breast cancer screening program
with CBE that incorporates community awareness and
mobilization, primary care-
based screening, enhanced
referral, and tracking processes in a resource-constrained
health system to facilitate timely diagnosis and treatment is feasible, and effective. The above findings seem
to be consistent with experiences from several countries
where the implementation of breast cancer awareness
programming in conjunction with capacity building to
increase equitable access to diagnosis and care, despite
the absence of population-based screening programs, has
resulted in substantial decreases in average breast cancer
stage at diagnosis, with steady declines in breast cancer
mortality rates.29 However, due to the relatively low age-
standardized incidence of breast cancer in rural India2
and the early age at which screening for breast cancer
is recommended in India’s national strategy (ie, age 30
years in the NPCDCS), many more women would need
to be screened and new cases detected in our program to
demonstrate clinical downstaging.
We might also hypothesize that community-based
programming, education, and mobilization by ASHAs,
8

along with quality CBE and patient navigation systems to
ensure timely diagnosis and treatment, might have downstream impacts on future clinical downstaging for women
who ultimately develop breast cancer, in India. This is
supported by previous work by the BHGI32 and a study
conducted in Peru that reported women who underwent
CBE were more likely to be diagnosed with an early stage
of breast cancer.33
Recommendations

To implement an evidence-based, resource-appropriate
breast cancer program, we recommend the following:
• Institutionalize creation of breast health awareness
through the existing community-based platforms.
• Saturate the primary health care capacity to offer quality CBE and patient navigation services for breast
cancer.
• Implement incentives for frontline health workers to
strengthen community mobilization and follow-up of
women with a positive CBE result.
• Integrate breast cancer screening with existing primary
health care system and national programs and schemes
for better coordination and outreach.
• Integrate technology solutions for decentralizing triaging and diagnostics (eg, portable ultrasound machine,
telepathology) services to district-level facilities.
• Develop patient navigation strategies at all levels: community, screening, diagnostics, and treatment.
• Implement robust data collection and management
systems for enabling evidence-based decision-making
at all levels.
• Improve resource allocation for breast cancer care
services.
In conclusion, results from the first 18 months of
the BHI demonstrate the feasibility and effectiveness of
implementing a large-scale, decentralized, and context-
appropriate breast cancer early detection program in
India. Breast health education, delivered through frontline health workers as a part of the routine home and
community visits, can be an effective means for mobilizing women to the primary health care facilities for CBE.
Our results demonstrate that it is feasible to build the
capacity of primary-level health care providers for conducting high-quality CBEs. The increase in adherence
over time, for women with an abnormal CBE visiting
the diagnostic center, coupled with reductions in the
time to final diagnosis and downstaging are suggestive
of the effectiveness of the patient-tracking and referral
Cancer  
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system. This is a very encouraging result, as early detection and diagnosis directly influence survival, provided
that appropriate care is available and affordable. The strategic plan was codesigned with the respective state governments and the government of India, and conscious
efforts were made to avoid the creation of a parallel, nonreplicable system.
Especially noteworthy is the finding that, during the
rollout of this plan, existing resources and platforms were
used to integrate the care pathway within the ongoing
primary health care system, which will facilitate both its
scalability and its sustainability.
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